Musculoskeletal and joints

Educational resources

Front cover image

The unrecognised epidemic of vitamin D deficiency in Black, Asian and Minority Ethnic (BAME) groups: a consensus document

Commissioned by STADA incorporating Thornton & Ross

Information intended for UK healthcare professionals only. This supplement has been commissioned and funded by STADA incorporating Thornton & Ross, who provided the content.
TR-088d  Date of preparation: August 2021

Cosentyx (secukinumab) TA card

NICE Technology Appraisal 719: Secukinumab for treating non-radiographic axial spondyloarthritis

Commissioned by Novartis Pharmaceuticals UK Ltd

The production of this Guidelines card has been commissioned by Novartis Pharmaceuticals UK Ltd. 
View Cosentyx (secukinumab) prescribing and adverse event reporting information
MLR ID 147195  August 2021

FINAL index image

Methofill® (methotrexate) SelfDose for the treatment of adult patients with rheumatoid arthritis, Crohn’s disease, and psoriasis*

Commissioned by Accord UK Ltd

Intended for UK Healthcare professionals only.
This promotional supplement has been commissioned and funded by Accord-UK Ltd and developed in partnership with Guidelines in Practice.
Click here for Methofill® (methotrexate) prescribing information and adverse event reporting
For full indications, please consult the summary of product characteristics.
UK-03037 | Date of preparation: May 2021

Evenity index image

Romosozumab▼ (Evenity®) 105mg solution for injection in prefilled pen SMC2280

Commissioned by UCB Pharma Ltd

The production of this Guidelines card has been commissioned by UCB Pharma Ltd. 
Amgen and UCB Pharma Ltd are co-developing Evenity®.
View prescribing information and adverse event reporting
UK-P-RM-OP-2000095 December 2020